Kerecis' Series A - II Round

Kerecis raised a round of funding on February 21, 2014.

Kerecis develops the MariGen Omega3 tissue-regeneration technology, a decellularized fish skin with cells and antigenic materials removed. Fish skin is made from the same material as human skin, with …

Articles about Kerecis' Series A - II Round: